mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.001 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.002 |
mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
paclitaxel |
gCSI |
pan-cancer |
AAC |
-0.19 |
0.002 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.002 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
Docetaxel |
gCSI |
pan-cancer |
AAC |
-0.19 |
0.003 |